Design, In Vitro Antimicrobial Evaluation, and In Silico Drug-Likeness Assessment of Novel Pyrazoline Derivatives

Authors

  • Alka Yadav
  • Sunita Gangwar
  • Udai Bhan Singh Rathore
  • Neeraj Sharma
  • Praveen Sharma

DOI:

https://doi.org/10.63682/jns.v14i32S.8377

Keywords:

ADME, Pyrazoline derivatives, Antimicrobial evaluation, RDKit tool, In-silico

Abstract

The present study reports the synthesis, In vitro antimicrobial evaluation, and in silico drug-likeness prediction of a novel series of pyrazoline derivatives (4a–4h). Antimicrobial activity was evaluated using the cup plate method against a panel of bacterial and fungal pathogens. The zone of inhibition was measured to assess antibacterial and antifungal efficacy. In silico studies were performed using a Python-based RDKit tool to determine key physicochemical parameters, ADME properties, and toxicity predictions. Compound 4h exhibited the most potent activity against all tested strains. All compounds showed favorable drug-likeness and high gastrointestinal absorption, with no AMES toxicity flags

Downloads

Download data is not yet available.

References

World Health Organization. Antimicrobial resistance: global report on surveillance. Geneva: WHO; 2023.

Sharma P, Jain P, Pahwa R, Gupta M. Pyrazoline derivatives as potential antimicrobial agents: a brief review. Eur J Med Chem. 2021;215:113256.

Ahmed SF, Ali MA, El-Meguid EA, El-Sherei MM. Synthesis and anti-inflammatory evaluation of some pyrazoline derivatives. Med Chem Res. 2020;29(3):449–459.

Zhang Y, Liu X, Gao Y, et al. Novel pyrazoline derivatives with potent anticancer activity: Design, synthesis, and biological evaluation. Bioorg Chem. 2022;121:105671.

Mishra A, Singh RK, Tiwari HK. Pyrazoline as a privileged scaffold in neuropharmacology: recent advances. Pharmacol Rep. 2022;74(3):657–672.

Sahu NK, Kohli DV, Agrawal AK. Recent developments in pyrazoline-based antimicrobial agents. Curr Med Chem. 2021;28(4):632–654.

Alqahtani WS, Sumathi R, Alzahrani E, et al. Pyrazoline and its derivatives as potent antifungal agents against resistant fungal strains. Antibiotics. 2023;12(4):654.

Awasthi R, Singh AK, Pandey R. Recent developments in pyrazoline-based hybrid molecules as antimicrobial agents. Future Med Chem. 2023;15(6):409–428.

Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7:42717.

Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001;46(1–3):3–26.

Cheng F, Li W, Zhou Y, et al. admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties. J Chem Inf Model. 2012;52(11):3099–3105.

Wang S, Liu H, Li D, et al. Prediction of hERG potassium channel blockage using machine learning methods. Mol Pharm. 2020;17(4):1340–1350.

Downloads

Published

2025-07-18

How to Cite

1.
Yadav A, Gangwar S, Singh Rathore UB, Sharma N, Sharma P. Design, In Vitro Antimicrobial Evaluation, and In Silico Drug-Likeness Assessment of Novel Pyrazoline Derivatives. J Neonatal Surg [Internet]. 2025Jul.18 [cited 2025Oct.14];14(32S):5801-5. Available from: https://jneonatalsurg.com/index.php/jns/article/view/8377